A New York State budget hearing descended into chaos as lawmakers grilled MTA Chairman Janno Lieber over a $35 million private security contract, with tensions boiling over into shouted interruptions and a demand for an apology.
Mayor Zohran Mamdani's push for fare-free buses has ignited a fierce debate in New York City, pitting the promise of equitable transit against stark questions of funding and feasibility.
A New York State budget hearing descended into chaos as lawmakers clashed over the effectiveness of a multi-million dollar private security contract intended to combat subway fare evasion, culminating in a shouting match and a sharp rebuke from the committee chair.
A veteran New York City driver, believing his E-ZPass account was current, was blindsided by a massive bill and a suspended registration, highlighting systemic issues with automated toll collection and penalty fees.
As New York City completes its shift to the OMNY contactless payment system, replacing the iconic MetroCard, concerns mount over the privacy implications of riders' data collection and sharing practices.
For decades, the cost of a New York City subway ride and a slice of pizza moved in lockstep, creating a quirky economic indicator. Now, soaring food costs and frozen transit fares have severed that iconic link, signaling deeper shifts in the city's affordability.
Biotech firms Erasca and Tango Therapeutics have entered a clinical collaboration to test a dual-targeted therapy against aggressive pancreatic and lung cancers, signaling a strategic deepening of Erasca's RAS-focused pipeline amid a challenging financial and clinical landscape.
A bold wild turkey brought an MTA bus to a complete stop in Staten Island, highlighting the borough's decades-long coexistence with a growing and often disruptive fowl population.
Metalla Royalty & Streaming Ltd. (TSXV:MTA) is transitioning toward a cash-generating phase as cornerstone royalty assets, including Ontario's Côté Gold and Brazil's Tocantinzinho, commence or near production. This move highlights the company's strategy of gaining exposure to precious metals while mitigating direct operational mining risks.
Novavax reported a profitable 2025, fueled by over $800M in partnership revenue. The biotech is successfully transitioning from a COVID-focused firm to a leaner, adjuvant-platform company, securing key deals with Pfizer and Sanofi while advancing its early-stage pipeline.
Outfront Media Inc. posted a 4.1% revenue increase for Q4 2025, powered by a 16% jump in transit advertising and strategic tech partnerships. The company is positioning for a major 2026 with the FIFA World Cup and election year spending expected to fuel further growth.
Scotiabank has increased its price target for Metalla Royalty & Streaming Ltd. (MTA) to $9, citing revised commodity assumptions. The move follows the company's report of near-doubled 2025 revenue, underscoring growth despite operational headwinds.
In his first major remarks as CEO, Malte Peters outlined Tango Therapeutics' strategy to advance its lead drug vopimetostat into pivotal trials for pancreatic cancer, while revealing promising early enrollment for its RAS inhibitor combination studies.
Metalla Royalty & Streaming (TSXV:MTA) has filed a shelf prospectus to raise up to $27.5 million, offering flexibility for future capital needs. While the move provides strategic optionality, it raises questions about valuation and shareholder dilution amidst a volatile market for precious metals royalty companies.
A Saturday morning attack at New York City's Grand Central Terminal saw a man armed with a machete injure three elderly individuals before being shot dead by police, authorities said, casting a shadow over one of the nation's busiest transit hubs.
Mayor Zohran Mamdani and Governor Kathy Hochul unveiled a plan to offer 2,000 free childcare spots for two-year-olds this year, scaling to 12,000 by next, funded without new taxes. The initiative marks the initial phase of Mamdani's flagship campaign pledge.
Amidst rising operational costs, Revolution Medicines (RVMD) reports robust financial health and outlines a decisive clinical strategy for its lead oncology assets, targeting pivotal trials in non-small cell lung cancer and pancreatic cancer through 2026.
As a historic winter storm bears down on New York, the financial world watches to see if the NYSE's famed trading floor will close. While electronic systems offer a backup, the potential absence of key personnel and the shadow of 'gap risk' loom large over Monday's market open.
At a recent industry summit, Amgen executives detailed a focused R&D strategy in oncology, emphasizing T-cell engagers and precision small molecules. Key updates included the expanding commercial footprint of IMDELLTRA and pivotal late-stage trials for LUMAKRAS aimed at moving into earlier lines of therapy.
A decade after its dramatic Shark Tank pitch, the innovative luggage brand Trunkster has vanished, leaving behind a trail of unfulfilled orders, frustrated crowdfunding backers, and a cautionary tale about the gap between televised deals and business reality.
